Biofrontera US is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions caused primarily by exposure to sunlight. It offers Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis; BF-RhodoLED lamp, photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis, and Belixos, an over-the-counter line of skin care cosmetic products.